InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $2.220 0.01 (0.45%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$828 Notification regarding unquoted securities - IDX 19 Sep 2024 2:45PM $2.570 $2.220 fallen by 13.62%
$828 Update - Dividend/Distribution - IDX 4 Sep 2024 5:53PM $2.610 $2.220 fallen by 14.94%
$828 Change in substantial holding 3 Sep 2024 4:06PM $2.610 $2.220 fallen by 14.94%
$828 Change of Director's Interest Notice - Ian Kadish 2 Sep 2024 4:38PM $2.580 $2.220 fallen by 13.95%
$828 Notification regarding unquoted securities - IDX 2 Sep 2024 4:37PM $2.580 $2.220 fallen by 13.95%
$828 CAJ: Proposed merger with IDX - Update 2 Sep 2024 10:13AM $2.570 $2.220 fallen by 13.62%
$828 Notification of cessation of securities - IDX 2 Sep 2024 9:00AM $2.600 $2.220 fallen by 14.62%
$828 Proposed merger with Capitol Health Limited - Update 2 Sep 2024 8:59AM $2.600 $2.220 fallen by 14.62%
$828 Change of Director's Interest Notice - Ian Kadish 30 Aug 2024 1:07PM $2.595 $2.220 fallen by 14.45%
$828 Notification of cessation of securities - IDX 30 Aug 2024 1:03PM $2.595 $2.220 fallen by 14.45%
$828 Dividend/Distribution - IDX 27 Aug 2024 9:06AM $2.570 $2.220 fallen by 13.62%
$828 Appendix 4G and Corporate Governance Statement 27 Aug 2024 9:03AM $2.570 $2.220 fallen by 13.62%
$828 FY24 Investor Presentation 27 Aug 2024 9:02AM $2.570 $2.220 fallen by 13.62%
$828 FY24 Results Announcement 27 Aug 2024 9:01AM $2.570 $2.220 fallen by 13.62%
$828 Appendix 4E and FY24 Annual Report 27 Aug 2024 9:00AM $2.570 $2.220 fallen by 13.62%
$828 2024 Annual General Meeting Date 22 Aug 2024 11:00AM $2.530 $2.220 fallen by 12.25%
$828 Release of shares from escrow 9 Aug 2024 12:02PM $2.435 $2.220 fallen by 8.83%
$828 Notification of cessation of securities - IDX 9 Aug 2024 12:01PM $2.435 $2.220 fallen by 8.83%
$828 Final Director's Interest Notice - Dr Jacqueline Milne 5 Aug 2024 2:05PM $2.450 $2.220 fallen by 9.39%
$828 Resignation of Executive Radiologist Director 5 Aug 2024 2:01PM $2.450 $2.220 fallen by 9.39%
$828 IDX FY24 Results Conference Call 31 Jul 2024 11:29AM $2.470 $2.220 fallen by 10.12%
$828 IDX/CAJ Merger Investor Presentation 18 Jul 2024 4:22PM $2.480 $2.220 fallen by 10.48%
$828 CAJ: CAJ enters into Merger Implementation Deed with IDX 18 Jul 2024 4:21PM $2.480 $2.220 fallen by 10.48%
$828 IDX & CAJ Sign Merger Implementation Deed 18 Jul 2024 4:21PM $2.480 $2.220 fallen by 10.48%
$828 Release of shares from escrow 18 Jun 2024 3:00PM $2.495 $2.220 fallen by 11.02%

176 - 200 of 784 results

Page 8 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.